CODI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Compass Diversified Holdings is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The technical setup is mixed-to-bullish short term, but the bigger picture is not strong enough to justify an immediate buy: no strong proprietary buy signal, neutral hedge fund and insider activity, weak congress sentiment, and analyst sentiment is only Neutral despite a higher target. Based on the current data, I would not buy it now; I would wait for clearer confirmation or a better entry.
CODI is in a short-term bullish structure with SMA_5 > SMA_20 > SMA_200, which supports an upward trend. MACD histogram is positive at 0.109 but contracting, suggesting momentum is still positive but losing strength. RSI_6 at 51.319 is neutral, so there is no oversold or overbought signal. Price at 10.82 is above the pivot at 10.637 and below R1 at 11.371, so the stock is trading in the middle of a range rather than breaking out. The modelled near-term pattern is not compelling, with an estimated -1.54% next-week and -5.51% next-month tendency.
["Bullish moving-average alignment (SMA_5 > SMA_20 > SMA_200)", "Positive MACD histogram, even though it is contracting", "B. Riley raised the price target to $10.50 from $8 after the Sterno sale, indicating some improvement in the company story", "Very bullish options positioning by open interest and volume ratios"]
["No AI Stock Picker signal today", "No recent SwingMax buy signal", "Hedge funds are neutral with no significant accumulation trends", "Insiders are neutral with no notable buying activity", "Congress trading shows 1 sale and 0 purchases, which leans negative", "Analyst rating remains Neutral, not Buy", "Short-term pattern data suggests weaker performance over the next week and month", "Financial snapshot was unavailable, so there is no strong latest-quarter growth confirmation"]
Latest quarter financial data was not available because the financial snapshot returned an error, so I cannot verify current revenue, earnings, or margin trends. The only available company-specific financial-related clue is the Sterno subsidiary sale, which analysts viewed as positive and potentially supportive of future divestitures. The latest quarter season could not be confirmed from the provided data.
Recent analyst trend is mildly improving but still cautious: B. Riley raised the target to $10.50 from $8 and kept a Neutral rating. That suggests the Street sees some value creation from asset sales, but not enough conviction to call it a strong buy. Wall Street pros appear split: the positive side is the divestiture progress, while the negative side is that the rating remains Neutral and the target is only slightly below the current price.
